Cerebrospinal Fluid Levels of Soluble Amyloid Precursor Protein and β-Amyloid 42 in Patients with Multiple Sclerosis, Neuromyelitis Optica and Clinically Isolated Syndrome

Author： Mai W   Hu X   Lu Z   Peng F   Wang Y  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.39, Iss.6, 2011-11, pp. : 2402-2413

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Soluble Amyloid-&bgr; Levels and Late-Life Depression

By  

Current Pharmaceutical Design, Vol. 20, Iss. 15, 2014-05 ,pp. : 2547-2554

Bentham Science Publishers

Access to resources Recommend Favorite

Neurotoxicity of &bgr;-Amyloid Protein: Oligomerization, Channel Formation and Calcium Dyshomeostasis

By  

Current Pharmaceutical Design, Vol. 16, Iss. 25, 2010-01 ,pp. : 2779-2789

Bentham Science Publishers

Access to resources Recommend Favorite

Multivalent & Multifunctional Ligands to &bgr;-Amyloid

By  

Current Pharmaceutical Design, Vol. 15, Iss. 6, 2009-02 ,pp. : 637-658

Bentham Science Publishers

Access to resources Recommend Favorite

Amyloid Beta Protein and Tau in Cerebrospinal Fluid and Plasma as Biomarkers for Dementia: A Review of Recent Literature

By  

Current Clinical Pharmacology, Vol. 3, Iss. 2, 2008-05 ,pp. : 123-131

Bentham Science Publishers

Access to resources Recommend Favorite

Rationalizing a pharmacological intervention on the amyloid precursor protein metabolism

By Racchi M.   Govoni S.  

Trends in Pharmacological Sciences, Vol. 20, Iss. 10, 1999-10 ,pp. : 418-423

Elsevier

Access to resources Recommend Favorite